Gonadotropin releasing hormone agonist trigger in oocyte donors co treated with a gonadotropin releasing hormone antagonist A dose finding study

Monday, February 1, 2016
Comparable numbers of mature oocytes and top quality embryos are retrieved after the use of triptorelin doses of 0.2, 0.3, or 0.4 mg to trigger ovulation in oocyte donors.

Read More

Gonadotropin releasing hormone agonist trigger in clinical in vitro fertilization Can the suboptimal candidate be defined?

Tuesday, September 1, 2015
Reflections on "Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles" by Meyer et al.

Read More

Translate »